Cullinan Oncology Inc. (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
7.67
0.09 (1.19%)
At close: Aug 15, 2025, 3:59 PM
7.66
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
Cullinan Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -206.76M | -178.74M | -167.38M | -143.54M | -142.16M | -132.35M | -153.34M | -156.63M | -142.33M | 63.95M | 109.19M | 102.08M | 108.71M | -81.8M | -67.48M | -62.38M | -55.44M | -52.88M |
Depreciation & Amortization | 306K | 306K | 306K | 306K | 310K | 314K | 310K | 292K | 221K | 152K | 93K | 46K | 50K | 51K | 53K | 56K | 58K | 61K |
Stock-Based Compensation | 38.33M | 38.97M | 37.82M | 35.71M | 34.02M | 31.41M | 30.44M | 30.43M | 27.96M | 28.65M | 27.96M | 32.59M | 31.88M | 27.43M | 24.38M | 27.14M | 22.58M | 18.42M |
Other Working Capital | 8.15M | 4.03M | 423K | -3.06M | -2.99M | -9.1M | -1.35M | -9.28M | -43.97M | 12.42M | 11.69M | 22.45M | 57.48M | 3.75M | 1.29M | -3.34M | -2.74M | -1.23M |
Other Non-Cash Items | -12.45M | -14.47M | -15.66M | -11.25M | -9.53M | -9.05M | -6.92M | -27.84M | -24.47M | -277.4M | -275.08M | -321.13M | -321.28M | -65.02M | -64.25M | 1.98M | 2.88M | 9.47M |
Deferred Income Tax | n/a | n/a | n/a | -6.13M | -5.52M | -4.42M | -4.42M | 21.28M | 20.67M | 19.57M | n/a | 47.63M | 48.54M | 49.34M | 67.42M | 310K | -599K | -1.4M |
Change in Working Capital | 9.06M | 3.72M | -389K | -1.9M | -3.92M | -7.42M | -339K | -8.66M | -43.39M | 9.33M | 11.18M | 21.94M | 59.07M | 6.17M | -3.54M | -4.8M | -5.7M | 58K |
Operating Cash Flow | -171.53M | -150.21M | -145.3M | -126.81M | -126.81M | -121.53M | -134.28M | -141.13M | -161.34M | -155.75M | -126.66M | -116.85M | -73.05M | -63.83M | -43.43M | -37.7M | -36.22M | -26.27M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -49K | -208K | -1.09M | -1.34M | -1.29M | -1.13M | -251K | n/a | n/a | n/a | 1K | -3K | -7K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -12.16K | -27.5K | -5.03M | -27.5K | -15.34K | n/a | 5M | n/a | 923K | 923K | -527K | -527K | n/a |
Purchase of Investments | -469.2M | -715.6M | -721.13M | -619.11M | -659.09M | -415.61M | -373.38M | -467.79M | -455.14M | -410.04M | -377.92M | -294.76M | -255.93M | -433.07M | -525.81M | -470.05M | -400.93M | -188.44M |
Sales Maturities Of Investments | 595.25M | 603.14M | 584.82M | 518.3M | 495.44M | 449.24M | 409.4M | 424.51M | 392.09M | 365.68M | 352.93M | 281.73M | 280.04M | 271.73M | 192.04M | 163.58M | 118.11M | 70.74M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 12.16K | 27.5K | 5.12M | 10.12M | 280.11M | 314.8M | 293.85M | 263.26M | -161.34M | -333.77M | -305.02M | -281.37M | -125.32M |
Investing Cash Flow | 126.05M | -112.47M | -136.31M | -100.81M | -163.64M | 33.58M | 35.81M | -44.27M | -59.29M | 229.45M | 248.97M | 261.72M | 294.11M | -161.34M | -333.77M | -306.47M | -282.82M | -116.26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | 1.82M | -375K | -375K | -375K | -1.4M | 800K | 800K | 800K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -656K | -4.45M | -4.45M | -4.45M | -3.97M | 38.42M | 38.39M | 7.68M | 9.28M | -27.31M | -24.53M | 8.88M | 8.04M | 6.95M | 1.52M | -1.13M | -503K | -1.43M |
Financial Cash Flow | 3.28M | 265.1M | 266.19M | 264.85M | 263.64M | 40.05M | 40.75M | 7.59M | 8.9M | -27.68M | -25.93M | 9.68M | 8.84M | 7.75M | 268.78M | 390.98M | 391.61M | 390.68M |
Net Cash Flow | -42.2M | 2.43M | -15.43M | 37.24M | -26.81M | -47.9M | -57.72M | -177.81M | -211.73M | 46.01M | 96.38M | 154.55M | 229.89M | -217.42M | -108.42M | 46.81M | 72.57M | 248.16M |
Free Cash Flow | -171.53M | -150.21M | -145.3M | -126.81M | -126.81M | -121.57M | -134.48M | -142.22M | -162.68M | -157.04M | -127.8M | -117.1M | -73.05M | -63.83M | -43.43M | -37.7M | -36.22M | -26.28M |